Summary
- Current Price
- As of today, ANTX price is $1.70, up +26.87% in the most recent trading session on
- Current Price All-Time High
- ANTX price is currently -92.79% below its historical high of $23.58 set on
- Market Cap
- ANTX current market cap is $47M, up +24.56% over the past 365 days
- PE Ratio
- ANTX PE ratio is unknown
- Revenue
- ANTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ANTX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | AN2 Therapeutics, Inc. |
| Ticker | NASDAQ: ANTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | an2therapeutics.com |
| Employees | 22 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.70 | ||
| Price, 1D Change | +26.87% | |
| $47M | ||
| - | ||
| - | ||
| 0.65 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.72 | ||
| EPS, 1Y Change | +37.27% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | ANMTU | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.72 | ||
| EPS Estimate | N/A | -$1.12 |
| EPS Est. Change | N/A | +34.91% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.70 | ||
| Price Target | - | $1.00 |
| Price Tgt. Change | - | -41.18% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.98 | -$2.74 | +7.96% | |
| -$1.63 | -$1.72 | -5.56% | |
| -$1.12 | N/A | +34.91% | |
| -$0.91 | N/A | +47.11% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +36.00% | ||
| -83.51% | ||
| +24.56% | ||
| -76.71% | ||
| 0.00% | ||
| 0.00% | ||
| +37.27% | ||
| -14.92% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.70 | ||
| $1.15 | ||
| SMA 200 vs Price | -32.61% | |
| $1.13 | ||
| SMA 50 vs Price | -33.58% | |
| 0.65 | ||
| $0.07 | ||
| 70.67 | ||
| 139.14% | ||
| 60.61% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.72 | ||
| $0.00 | ||
| - | ||
| -$54.55M | ||
| - | ||
| -$51.32M | ||
| - | ||
| -$54.55M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 8.43 | ||
| 8.43 | ||
| - | ||
| - | ||
| -1.36 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.77 | ||
| 0.41 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $81.85M | ||
| $83.62M | ||
| $92.09M | ||
| $86.26M | ||
| $10.24M | ||
| $10.24M | ||
| $0.00 | ||
| $0.00 | ||
| $3.32M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $51.32M | ||
| $54.55M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$49.26M | ||
| $54.59M | ||
| $372.00K | ||
| $0.00 | ||
| -$49.26M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JMP Securities | → | |
| Citizens Capital Markets | → | |
| Citizens Capital Markets | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| TD Cowen | → | |
| JMP Securities | → | |
| Leerink Partners | → | |
| Evercore ISI Group | → | |
| JMP Securities | → |
Analyst sentiment
Institutional ownership
Screeners with ANTX
FAQ
What is the ticker symbol for AN2 Therapeutics, Inc.?
The ticker symbol for AN2 Therapeutics, Inc. is NASDAQ:ANTX
Does AN2 Therapeutics, Inc. pay dividends?
No, AN2 Therapeutics, Inc. does not pay dividends
What sector is AN2 Therapeutics, Inc. in?
AN2 Therapeutics, Inc. is in the Healthcare sector
What industry is AN2 Therapeutics, Inc. in?
AN2 Therapeutics, Inc. is in the Biotechnology industry
What country is AN2 Therapeutics, Inc. based in?
AN2 Therapeutics, Inc. is headquartered in United States
When did AN2 Therapeutics, Inc. go public?
AN2 Therapeutics, Inc. initial public offering (IPO) was on March 25, 2022
Is AN2 Therapeutics, Inc. in the S&P 500?
No, AN2 Therapeutics, Inc. is not included in the S&P 500 index
Is AN2 Therapeutics, Inc. in the NASDAQ 100?
No, AN2 Therapeutics, Inc. is not included in the NASDAQ 100 index
Is AN2 Therapeutics, Inc. in the Dow Jones?
No, AN2 Therapeutics, Inc. is not included in the Dow Jones index
When was AN2 Therapeutics, Inc. last earnings report?
AN2 Therapeutics, Inc.'s most recent earnings report was on August 14, 2025
When does AN2 Therapeutics, Inc. report earnings?
The date for AN2 Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ANTX Official Website www.an2therapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1880438/000095017025044366/0000950170-25-044366-index.htm
- ANTX Profile on Yahoo Finance finance.yahoo.com/quote/ANTX
- ANTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/antx